Bioceres (NYSE: BIOX) shares Q4 and FY 2025 results and Rizobacter FS

Rhea-AI Filing Summary

Bioceres Crop Solutions Corp. furnished a Form 6-K to provide investors access to two key documents. First, the company attached a press release announcing its fourth fiscal quarter and full fiscal year 2025 financial and operational results as Exhibit 99.1. Second, it included as Exhibit 99.2 the consolidated financial statements of its subsidiary Rizobacter Argentina S.A. for the fiscal year ended June 30, 2025, as filed with the Argentine securities regulator. This filing mainly serves as a communication vehicle, making these results and subsidiary financial statements available to the market.

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer 

Pursuant to Rules 13a-16 or 15d-16 under 

the Securities Exchange Act of 1934

For the month of September 2025

Commission File Number: 001-38836

BIOCERES CROP SOLUTIONS CORP. 

(Translation of registrant’s name into English)

Ocampo 210 bis, Predio CCT, Rosario 

Province of Santa Fe, Argentina 

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F  x                                                              Form 40-F  ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

EXPLANATORY NOTE

On September 9, 2025, Bioceres Crop Solutions Corp. (the “Company”) published a press release announcing its fourth fiscal quarter and fiscal year 2025 financial and operational results, a copy of which is filed herewith as Exhibit 99.1.

On September 8, 2025, Rizobacter Argentina S.A., a subsidiary of the Company, filed its consolidated financial statements for the fiscal year ended June 30, 2025, with the Comisión Nacional de Valores in Argentina, a copy of which, provided as a convenience translation, is filed herewith as Exhibit 99.2.

Exhibit List

Exhibit No.		Description
99.1		Press release, Bioceres Crop Solutions Corp. reports fourth fiscal quarter and fiscal year 2025 financial and operational results.
99.2		Rizobacter Argentina S.A.’s consolidated financial statements for the fiscal year ended June 30, 2025, presented in comparative form.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		BIOCERES CROP SOLUTIONS CORP.
		(Registrant)
Dated: September 9, 2025	By:	By:	/s/ Federico Trucco
		Name:	Federico Trucco
		Title:	Chief Executive Officer

FAQ

What does Bioceres Crop Solutions Corp. (BIOX) disclose in this Form 6-K?

The Form 6-K from Bioceres Crop Solutions Corp. furnishes a press release with the company’s fourth fiscal quarter and fiscal year 2025 financial and operational results as Exhibit 99.1, and the consolidated financial statements of its subsidiary Rizobacter Argentina S.A. for the fiscal year ended June 30, 2025 as Exhibit 99.2.

Which financial period is covered by Rizobacter Argentina S.A.’s statements in the BIOX Form 6-K?

The filing states that Rizobacter Argentina S.A.’s consolidated financial statements included as Exhibit 99.2 cover the fiscal year ended June 30, 2025, and these statements were filed with the Argentine securities regulator.

What information is in Exhibit 99.1 of Bioceres Crop Solutions Corp. (BIOX) Form 6-K?

Exhibit 99.1 is a press release in which Bioceres Crop Solutions Corp. reports its fourth fiscal quarter and fiscal year 2025 financial and operational results.

What information is in Exhibit 99.2 of the BIOX Form 6-K?

Exhibit 99.2 contains the consolidated financial statements of Rizobacter Argentina S.A., a subsidiary of Bioceres Crop Solutions Corp., for the fiscal year ended June 30, 2025, presented in comparative form.

Why did Bioceres Crop Solutions Corp. (BIOX) file this Form 6-K?

The company filed this Form 6-K to formally provide investors with its press release on fourth quarter and fiscal year 2025 results and with the consolidated financial statements of its subsidiary Rizobacter Argentina S.A. as filed with the Argentine regulator.

Who signed the Bioceres Crop Solutions Corp. (BIOX) Form 6-K?

The Form 6-K was signed on behalf of Bioceres Crop Solutions Corp. by Federico Trucco, who is identified as the company’s Chief Executive Officer.